|
Report Date : |
17.05.2013 |
IDENTIFICATION DETAILS
|
Name : |
DSM NUTRITIONAL PRODUCTS AG |
|
|
|
|
Registered Office : |
Wurmisweg 576 4303 Kaiseraugst/AG |
|
|
|
|
Country : |
Switzerland |
|
|
|
|
Financials (as on) : |
31.12.2012 |
|
|
|
|
Date of Incorporation : |
1933 |
|
|
|
|
Com. Reg. No.: |
270.3.012.805-7 / 611303 |
|
|
|
|
Legal Form : |
Company limited by shares |
|
|
|
|
Line of Business : |
Manufacture and distribution of vitamins, carotenoids and other fine
chemicals to the feed, food, pharmaceutical and personal care industries. |
|
|
|
|
No. of Employees : |
1'000 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Switzerland |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SWITZERLAND - ECONOMIC OVERVIEW
Switzerland is a peaceful, prosperous, and modern market
economy with low unemployment, a highly skilled labor force, and a per capita
GDP among the highest in the world. Switzerland's economy benefits from a
highly developed service sector, led by financial services, and a manufacturing
industry that specializes in high-technology, knowledge-based production. Its
economic and political stability, transparent legal system, exceptional
infrastructure, efficient capital markets, and low corporate tax rates also
make Switzerland one of the world's most competitive economies. The Swiss have
brought their economic practices largely into conformity with the EU's to
enhance their international competitiveness, but some trade protectionism
remains, particularly for its small agricultural sector. The fate of the Swiss
economy is tightly linked to that of its neighbors in the euro zone, which
purchases half of all Swiss exports. The global financial crisis of 2008 and
resulting economic downturn in 2009 stalled export demand and put Switzerland
in a recession. The Swiss National Bank (SNB) during this period effectively
implemented a zero-interest rate policy to boost the economy as well as prevent
appreciation of the franc, and Switzerland's economy recovered in 2010 with
3.0% growth. The sovereign debt crises currently unfolding in neighboring
euro-zone countries pose a significant risk to Switzerland's financial
stability and are driving up demand for the Swiss franc by investors seeking a
safe-haven currency. The independent SNB has upheld its zero-interest rate
policy and conducted major market interventions to prevent further appreciation
of the Swiss franc, but parliamentarians have urged it to do more to weaken the
currency. The franc's strength has made Swiss exports less competitive and
weakened the country's growth outlook; GDP growth fell to 1.9% in 2011 and 0.8%
in 2012. Switzerland has also come under increasing pressure from individual
neighboring countries, the EU, the US, and international institutions to reform
its banking secrecy laws. Consequently, the government agreed to conform to
OECD regulations on administrative assistance in tax matters, including tax
evasion. The government has renegotiated its double taxation agreements with
numerous countries, including the US, to incorporate the OECD standard, and is
considering the possibility of imposing taxes on bank deposits held by
foreigners. These steps will have a lasting impact on Switzerland's long
history of bank secrecy.
|
Source
: CIA |
DSM NUTRITIONAL PRODUCTS AG
Operating address:
Wurmisweg 576 Branch
Werk Sisseln:
4303 Kaiseraugst/AG Hauptstrasse
4
Switzerland/CH 4334
Sisseln/AG
Switzerland/CH
Telephone: 061 8158888 062 8662111
Fax: 061 8158880 062 8662510
Web site: http://www.dsm.com
E-mail: info.dnp@dsm.com
VAT-No.: CHE102267951
Established: 1933
Line of Business: Chemicals
Industry Division: Manufacturing
Industry-code (NACE): 2053 Manufacture of essential oils
2059 Manufacture of other chemical products
n.e.c.
Import/Export: Import,
Export
Quality certification: ISO
9001:2000 (since 1991)
ISO
14001:1996 (since 2004)
Banks: unknown
Coverage: Company
Figures: estimated
Employees: 1'000
Sales: CHF 400-600
Mio
Branches: 4
The business activities includes the manufacture and distribution of
vitamins, carotenoids and other fine chemicals to the feed, food,
pharmaceutical and personal care industries.
Real Estate: The
company owns buildings.
Company
No: 270.3.012.805-7 / 611303
Legal
form: Company limited by
shares
Registration: 01.05.2001
Legal
status: active
Responsible
Register: Handelsregister des Kantons
Aargau (since 22.12.2003)
History: Date of Statutes:
16.12.2003
Date of
Statutes: 20.09.2001
Date of
Statutes: 11.06.2001
Date of
Incorporation Statutes: 20.04.2001
Date of
Statutes: 16.12.2011
Date of
Statutes: 11.12.2009
Date of
Statutes: 03.06.2004
Entry Deleted Name
15.06.2004 DSM
Nutritional Products AG
15.06.2004 DSM
Nutritional Products SA (Name translated)
15.06.2004 DSM
Nutritional Products Ltd (Name translated)
15.06.2004 Roche Vitamins AG
15.06.2004 Roche Vitamins SA (Name translated)
15.06.2004 Roche Vitamins Ltd (Name translated)
Entry Deleted Legal domicile
22.12.2003 Kaiseraugst,
Switzerland
22.12.2003 Basel, Switzerland
Entry Deleted Address
22.12.2003 Wurmisweg
576, 4303 Kaiseraugst/AG, Switzerland/CH
22.12.2003 Grenzacherstr. 124, 4070 Basel/BS, Switzerland/CH
Entry Deleted Capital
active Share
Capital CHF 50'000'000, paidup CHF 50'000'000
Entry Deleted Capital Structure
active 50'000
Registered shares of CHF 1'000.--
Entry Deleted Activity (original Language)
04.01.2012 Herstellung,
Vertrieb und Verwertung von Vitaminen, Feinchemikalien, Wirkstoffen und
verwandten Produkten; kann Grundstücke erwerben, belasten und veräussern,
Zweigniederlassungen und Tochtergesellschaften errichten, sich an anderen
Unternehmen beteiligen, für ihre Aktionäre oder für andere
Konzerngesellschaften Sicherheiten bestellen und Garantien abgeben sowie
Darlehen gewähren. Die Gesellschaft ist in wirtschaftlicher,
organisatorischer und rechtlicher Hinsicht in eine Gruppe von Gesellschaften
(Konzern) eingebunden und bezweckt somit auch die Verfolgung und Wahrung der
berechtigten Konzerninteressen. Im Rahmen der gesetzlichen Vorschriften richtet
die Gesellschaft ihre Tätigkeit auf den Konzern aus und berücksichtigt dabei
insbesondere auch konzerninterne Weisungen.
15.06.2004 Herstellung, Vertrieb und Verwertung von
Vitaminen, Vitaminprodukten und Feinchemikalien aller Art. Die Gesellschaft
kann Grundstücke erwerben, bewirtschaften und veräussern und sich an anderen
Unternehmungen beteiligen, die gleiche, ähnliche oder verwandte Ziele
verfolgen.
15.12.2009 04.01.2012 Herstellung, Vertrieb und Verwertung von
Vitaminen, Feinchemikalien, Wirkstoffen und verwandten Produkten; kann
Grundstücke erwerben, belasten und veräussern, Zweigniederlassungen und
Tochtergesellschaften errichten, sich an anderen Unternehmen beteiligen,
für ihre Aktionäre oder für andere Konzerngesellschaften Sicherheiten
bestellen und Garantien abgeben sowie Darlehen gewähren.
15.06.2004 15.12.2009 Herstellung, Vertrieb und Verwertung von
Vitaminen, Feinchemikalien, Wirkstoffen und verwandten Produkten; kann
Grundstücke erwerben, belasten und veräussern, Zweigniederlassungen und
Tochtergesellschaften errichten, sich an anderen Unternehmen jeglicher Art
beteiligen.
Entry Deleted Remarks (original Language)
active Publishing
authority: SHAB.
active Contribution
in kind/Asset takeover: Geschäftsbereich 'Vitamine und Feinchemikalien' der
"F. Hoffmann-La Roche AG", in Basel, gemäss Vertrag vom 20.09.2001 und
Bilanz per 30.06.2001 zum Preis von CHF 149'900'000.--, wofür 49'900
Namenaktien zu CHF 1'000.-- ausgegeben werden.
15.12.2009 Reports:
Mitteilungen an die Aktionäre erfolgen schriftlich.
18.12.2007 Merger:
Übernahme der Aktiven und Passiven der Therapo AG, in Basel
(CH-270.3.005.213-3), gemäss Fusionsvertrag vom 11.12.2007 und Bilanz per
30.06.2007. Aktiven von CHF 1'056'660.71 und Passiven (Fremdkapital) von CHF
653'414.49 gehen auf die übernehmende Gesellschaft über. Da die übernehmende
Gesellschaft sämtliche Aktien der übertragenden Gesellschaft hält, findet weder
eine Kapitalerhöhung noch eine Aktienzuteilung statt.
18.12.2007 Merger:
Übernahme der Aktiven und Passiven der Pentapharm AG, in Basel
(CH-270.3.002.808-8), gemäss Fusionsvertrag vom 11.12.2007 und Bilanz per
30.06.2007. Aktiven von CHF 37'843'033.39 und Passiven (Fremdkapital) von CHF
25'074'223.94 gehen auf die übernehmende Gesellschaft über. Da die übernehmende
Gesellschaft sämtliche Aktien der übertragenden Gesellschaft hält, findet weder
eine Kapitalerhöhung noch eine Aktienzuteilung statt.
18.12.2007 Merger:
Übernahme der Aktiven und Passiven der Pentapharm Holding AG, in Basel
(CH-270.3.004.298-1), gemäss Fusionsvertrag vom 11.12.2007 und Bilanz per
30.06.2007. Aktiven von CHF 34'792'363.93 und Passiven (Fremdkapital) von CHF
13'368'486.65 gehen auf die übernehmende Gesellschaft über. Da dieselben
Aktionäre sämtliche Aktien der an der Fusion beteiligten Gesellschaften halten,
findet weder eine Kapitalerhöhung noch eine Aktienzuteilung statt.
26.06.2006 Merger:
Übernahme der Aktiven und Passiven der Crina S.A., in Gland
(CH-550-0.102.201-9), gemäss Fusionsvertrag vom 23.06.2006 und Bilanz per
31.12.2005 Aktiven von CHF 3'012'734.-- und Passiven (Fremdkapital) von CHF
1'796'804.-- gehen auf die übernehmende Gesellschaft über. Da dieselben
Aktionäre sämtliche Aktien der an der Fusion beteiligten Gesellschaften halten,
findet weder eine Kapitalerhöhung noch eine Aktienzuteilung statt.
Entry Deleted Branches
05.02.2008 Engelgasse
109, 4052 Basel, BS, Switzerland/CH
23.01.2008 ,
3931 Eyholz, VS, Switzerland/CH
19.07.2006 Rue
de la Combe 15, 1196 Gland, VD, Switzerland/CH
24.06.2004 Hauptstrasse
4, 4334 Sisseln, AG, Switzerland/CH
Title Name
President Christoph Goppelsroeder, Origin:
Basel, Switzerland, Residential address: Binningen, Switzerland, joint
signature of two, Registered since: 21.03.2013
Director Dr. Manfred Eggersdorfer, Origin:
Germany, Residential address: Stein/AG, Switzerland, joint signature of two
Director Robert Kiemeneij, Origin:
Netherlands, Residential address: Basel, Switzerland, joint signature of two,
Registered since: 21.03.2013
Title Name
Director Mauricio
Adade, Origin: Brazil, Residential address: Arlesheim/BL, Switzerland, joint
signature of two
Director Dr. Thomas
McClymont, Origin: United Kingdom, Residential address: 4103 Bottmingen/BL,
Switzerland, joint signature of two
Director Monique
Musch, Origin: Netherlands, Residential address: 4105 Biel-Benken/BL, Switzerland,
joint signature of two
Member
with signing authority Gabriele
Allard-Rudloff, Origin: Germany, Residential address: Rheinfelden, Switzerland,
joint signature of two, Registered since: 21.03.2013
Member
with signing authority Philippe
Becquet, Origin: France, Residential address: Mulhouse, France, joint signature
of two, Registered since: 06.02.2012
Member
with signing authority Katja Berg,
Origin: Germany, Residential address: Muttenz, Switzerland, joint signature of
two, Registered since: 06.02.2012
Member
with signing authority Pamela Berger,
Origin: Austria, Residential address: Basel, Switzerland, joint signature of
two, Registered since: 06.02.2012
Member
with signing authority Antoine De
Saizieu, Origin: France, Residential address: Brunstatt, France, joint
signature of two
Member
with signing authority Roland Dux,
Origin: Spreitenbach, Switzerland, Residential address: Spreitenbach,
Switzerland, joint signature of two, Registered since: 06.02.2012
Member
with signing authority Dr. Gerhard Gans, Origin: Germany, Residential address:
Rheinfelden-Herten, Germany, joint signature of two
Member
with signing authority Anne-Gael
Glevarec, Origin: France, Residential address: Basel/BS, Switzerland, joint
signature of two, Registered since: 23.10.2009
Member
with signing authority Richard
Alphonse (Rick) Greubel, Origin: United States of America, Residential address:
Basel, Switzerland, joint signature of two, Registered since: 06.10.2010
Member
with signing authority Ilona Haaijer,
Origin: Netherlands, Residential address: Basel, Switzerland, joint signature
of two, Registered since: 06.10.2010
Member
with signing authority Dr.
Stephan Heck, Origin: Germany,
Residential address: Rheinfelden, Germany, joint signature of two
Member
with signing authority Jean-François
Hecquet, Origin: Belgium, Residential address: Füllinsdorf, Switzerland, joint
signature of two, Registered since: 23.10.2009
Member
with signing authority Ursula
Hermetschweiler, Origin: Wetzikon, Switzerland, Residential address: Baden,
Switzerland, joint signature of two, Registered since: 23.10.2009
Member
with signing authority Dr. Georg Kau,
Origin: Germany, Residential address: Grenzach-Wyhlen, Germany, joint signature
of two
Member
with signing authority Dr. Beat
Kiser, Origin: Sarnen, Switzerland, Residential address: 4104 Oberwil /BL,
Switzerland, joint signature of two
Member
with signing authority Jan Kriegel,
Origin: Germany, Residential address: Binningen, Switzerland, joint signature
of two, Registered since: 06.02.2012
Member
with signing authority Manfred Kurt,
Origin: Roggwil BE, Switzerland, Residential address: Binningen, Switzerland,
joint signature of two, Registered since: 06.02.2012
Member
with signing authority Dr. Landry Le
Chevanton, Origin: France, Residential address: Bartenheim, France, joint
signature of two
Member
with signing authority Dr.
Bernd-Dieter Letzelter, Origin: Germany, Residential address: Basel,
Switzerland, joint signature of two
Member
with signing authority Lucia Martinez
Ruiz, Origin: Spain, Residential address: Basel, Switzerland, joint signature
of two, Registered since: 06.02.2012
Member
with signing authority Stefan Peters,
Origin: Germany, Residential address: Merzhausen, Germany, joint signature of
two, Registered since: 06.02.2012
Member
with signing authority Boris
Pimentel, Origin: Zürich, Switzerland, Residential address: Magden,
Switzerland, joint signature of two, Registered since: 23.10.2009
Member
with signing authority Dr. Birgit
Rabanus, Origin: Germany, Residential address: Basel, Switzerland, joint
signature of two
Member
with signing authority Dr. Krijn
Rietveld, Origin: Netherlands, Residential address: Basel, Switzerland, joint
signature of two
Member
with signing authority Kuno Josef
Schwander, Origin: Galgenen, Switzerland, Residential address: Bottmingen,
Switzerland, joint signature of two
Member
with signing authority Nadja
Seibel-Thomsen, Origin: Germany, Residential address: Lörrach, Germany, joint
signature of two, Registered since: 06.02.2012
Member
with signing authority Dr. Melanie
Steck, Origin: Germany, Residential address: Rheinfelden, Switzerland, joint
signature of two
Member
with signing authority Mark Stock,
Origin: United States of America, Residential address: Basel, Switzerland,
joint signature of two
Member
with signing authority Benedikt
Suter, Origin: Basel, Switzerland, Residential address: Basel, Switzerland,
joint signature of two
Member
with signing authority Jacoline van
Blokland-van Gooswilligen, Origin: Netherlands, Residential address: Arlesheim,
Switzerland, joint signature of two
Member
with signing authority Marinus
Vroege, Origin: Netherlands, Residential address: Oberwil/BL, Switzerland,
joint signature of two, Registered since: 21.03.2013
Member
with signing authority Dr. Ernst
Wagner, Origin: Germany, Residential address: Grenzach-Wyhlen, Germany, joint
signature of two
Member
with signing authority Mario
Witthüser, Origin: Germany, Residential address: Rheinfelden, Germany, joint
signature of two
Title Name
Auditor Ernst
& Young AG, Residential address: Basel, Switzerland
Title Name
Chief Business Segment Officer Mauricio
Adade
Consolidation: consolidated
Industry: Trade/Industry
Fiscal
year end: 31.12.2012 31.12.2011 31.12.2010 31.12.2009 31.12.2008
Number
of months: 12 12 12 12 12
Currency: mil.
EUR mil. EUR mil. EUR mil. EUR mil.
EUR
Operating
revenue 9'131.0 9'048.0 8'176.0 6'725.0 9'297.0
Operating
result 635.0 866.0 752.0 433.0 903.0
Result
before minority interests 288.0 814.0 507.0 337.0 577.0
Total
shareholders equity 5'874.0 5'784.0 5'481.0 4'949.0 4'633.0
Total
assets 11'966.0 11'157.0 10'480.0 9'614.0 9'653.0
Cost
of employees 1'761.0 1'655.0 1'566.0 1'532.0 1'465.0
Depreciation 500.0 502.0 440.0 474.0 451.0
Investments
in tangible fixed assets 528.0 427.0 472.0 587.0
Employees at year end 23'498 22'224 21'911 22'738 23'591
Employees average 23'157
Name: Koninklijke DSM
N.V.
City/Country: Heerlen, Netherlands/NL
No. of Owner/-s: 1
Owner: The company is
foreign owned.
Class: 100%
Name: DSM Nutritional
Products Holding AG
City/Country: Kaiseraugst/AG,
Switzerland/CH
Interest: 100.00% voting
right, 100.00% capital interest (since 2001)
Name: DSM Nutrition
Japan KK
City/Country: Tokyo, Japan/JP
Name: DSM Nutrition
Korea Ltd
City/Country: Seoul, South
Korea/KR
Name: DSM Nutritional
Products Argentina SA
City/Country: Buenos Aires,
Argentina/AR
Name: DSM Nutritional
Products AS
City/Country: Hvidovre,
Denmark/DK
Name: DSM Nutritional
Products Asia Pacific Pte Ltd
City/Country: Singapore,
Singapore/SG
Name: DSM Nutritional
Products Australia Pty Ltd
City/Country: French's
Forest/New South Wales, Australia/AU
Name: DSM Nutritional
Products Canada Inc
City/Country: Cambridge/Ontario,
Canada/CA
Name: DSM Nutritional
Products Chile SA
City/Country: Puerto Montt,
Chile/CL
Name: DSM Nutritional
Products Colombia SA
City/Country: Bogota,
Colombia/CO
Name: DSM Nutritional
Products Costa Rica SA
City/Country: San José, Costa
Rica/CR
Name: DSM Nutritional
Products Europe AG
City/Country: Kaiseraugst/AG,
Switzerland/CH
Name: DSM Nutritional
Products France SAS
City/Country: Paris la Défense,
France/FR
Name: DSM Nutritional
Products GmbH
City/Country: Grenzach-Wyhlen/Baden-Württemberg,
Germany/DE
Name: DSM Nutritional
Products Hellas Ltd
City/Country: N. Erythrea,
Greece/GR
Name: DSM Nutritional
Products Hungary Kft
City/Country: Újhartyán,
Hungary/HU
Name: DSM Nutritional
Products Inc
City/Country: Parsippany/New
Jersey, United States of America/US
Name: DSM Nutritional
Products Malaysia Sdn Bhd
City/Country: Kuala Lumpur,
Malaysia/MY
Name: DSM Nutritional
Products Mexico SA de CV
City/Country: El Salto/Jalisco,
Mexico/MX
Name: DSM NUTRITIONAL
PRODUCTS NEW ZEALAND LIMITED
City/Country: Auckland, New
Zealand/NZ
Name: DSM Nutritional
Products NV/SA
City/Country: Deinze,
Belgium/BE
Name: DSM Nutritional
Products Peru SA
City/Country: Lima, Peru/PE
Name: DSM Nutritional
Products Philippines Inc
City/Country: Makati/Metro
Manila, Philippines/PH
Name: DSM Nutritional
Products South Africa (Pty) Ltd
City/Country: Isando, South
Africa/ZA
Name: DSM Nutritional
Products Spzoo
City/Country: Mszczonow,
Poland/PL
Name: DSM Nutritional
Products Taiwan Ltd
City/Country: Taipei, Taiwan/TW
Name: DSM Nutritional
Products (UK) Limited
City/Country: Heanor/Derbyshire,
United Kingdom/GB
Name: DSM Nutritional
Products Vietnam Ltd
City/Country: Ho Chi Minh City,
Vietnam/VN
Name: DSM Produtos
Nutricionais Brasil Ltda
City/Country: Sao Paulo,
Brazil/BR
Name: Istituto delle
Vitamine SpA
City/Country: Mailand, Italy/IT
Name: Roche (China)
Ltd
City/Country: Shanghai,
China/CN
Name: Roche Vitaminas
Centroamericana y Caribe SA
City/Country: Puerto Cortés,
Honduras/HN
Name: Roche Vitaminas
Dominicana SA
City/Country: Santo Domingo,
Dominican Republic/DO
Name: Roche Vitaminas
Ecuador SA
City/Country: Quito, Ecuador/EC
Name: Roche Vitaminas
Guatemala SA
City/Country: Guatemala,
Guatemala/GT
Name: Roche Vitaminas
Interamérica SA
City/Country: Panama, Panama/PA
Name: Roche Vitaminas
SA
City/Country: Alcalá de
Henares/Madrid, Spain/ES
Name: Roche Vitaminas
Uruguay SA
City/Country: Montevideo,
Uruguay/UY
Name: Roche Vitaminas
Venezuela SA
City/Country: La Victoria,
Venezuela/VE
Name: Roche Vitamins
International Marketing Centre Epe
City/Country: Kifissia/Athen,
Greece/GR
Name: Rovigypt Ltd
City/Country: Giza, Egypt/EG
Name: Rovithai
Limited
City/Country: Bangkok,
Thailand/TH
Class: 100%
Name: DSM Nutritional
Products China Holding GmbH
City/Country: Kaiseraugst/AG,
Switzerland/CH
Interest: 100.00% voting
right, 100.00% capital interest
Class: 10-19%
Name: BEC AG
City/Country: Gipf-Oberfrick/AG,
Switzerland/CH
Interest: 10.00% voting
right, 10.00% capital interest
Control date Year No. Amount
CHF Status
21.08.2012 2012 0
21.08.2012 2011 0
21.08.2012 2010 1 600'000.-- Legal actions
21.08.2012 2009 1 6'600.-- Paid legal actions
21.08.2012 2008 0
17.08.2011 2007 0
08.12.2009 2006 0
08.12.2009 2005 0
An updated legal action check is only available against proof of interest.
e.g. a copy of an enquiry letter, and order or invoice relating to the subject
company.
Debt collection case:
AUG 2009: CHF 100.00, paid.
OCT 2010: CHF 8'964.00, paid.
NOV 2012: CHF 197.00.
Financial
Statements: The company does not
disclose any financial statements. Third parties are not permitted any insight
into the financial affairs. It is therefore difficult to make a proper
assessment of the actual situation.
Financial Situation: The
financial situation is good.
Payment experiences: Financial
obligations are paid promptly.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.77 |
|
|
1 |
Rs.83.31 |
|
Euro |
1 |
Rs.70.46 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.